Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes
NCT07458269 · Status: ENROLLING_BY_INVITATION · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2026-05-29
Summary
The primary objective of this study is to determine the effects of ribupatide administered by subcutaneous (SC) injection once weekly compared to placebo on percent change in body weight.
Conditions
Interventions
- DRUG
-
Ribupatide
SC Injection
- DRUG
-
SC Injection
Sponsors & Collaborators
-
Kailera
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-04
- Primary Completion
- 2027-05-31
- Completion
- 2027-06-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity
NCT07400679 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
NCT02453711 ·Status: COMPLETED ·Phase: PHASE2
-
A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients
NCT00391196 ·Status: TERMINATED ·Phase: PHASE3
-
A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects
NCT00134199 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes
NCT05950516 ·Status: UNKNOWN ·Phase: PHASE3
-
A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
NCT06577766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
NCT04605861 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of TG103 Injection in Non-diabetic Overweight or Obesity
NCT05997576 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
NCT02870231 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin
NCT06064006 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
NCT01511185 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of HS-20094 in Chinese Adults with Overweight or Obesity
NCT06839664 ·Status: RECRUITING ·Phase: PHASE3
-
Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
NCT03308721 ·Status: COMPLETED ·Phase: PHASE1
-
Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
NCT05040971 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
NCT06041217 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers
NCT01511159 ·Status: COMPLETED ·Phase: PHASE1
-
A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety
NCT00375401 ·Status: TERMINATED ·Phase: PHASE3
-
Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
NCT02235961 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
NCT07395687 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.
NCT00396448 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
NCT03486392 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers
NCT01515592 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
NCT04487743 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity
NCT06226090 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.
NCT04251156 ·Status: COMPLETED ·Phase: PHASE3